EcoDrugPlus

Melanocortin 1 Receptor

Ensembl ID : ENSNGAG00000016884
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSNGAG00000002843
Gene Symbol: MC3R
3 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSNGAG00000009428
Gene Symbol: MC4R
3 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSNGAG00000014380
Gene Symbol: MTNR1A
3 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSNGAG00000011830
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSNGAG00000019113
Gene Symbol: MME
2 Cross references
235 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSNGAG00000009368
Gene Symbol: METAP2
3 Cross references
214 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSNGAG00000002943
Gene Symbol: MAPT
3 Cross references
255 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSNGAG00000017072
Gene Symbol: MAPK1
3 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSNGAG00000009045
Gene Symbol: MAPK10
3 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSNGAG00000001344
Gene Symbol: MAPK11
3 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSNGAG00000010289
Gene Symbol: MAPK14
3 Cross references
281 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).